Comparison of left ventricular reverse remodeling induced by cardiac contractility modulation and cardiac resynchronization therapy in heart failure patients with different QRS durations
- PMID: 22330007
- DOI: 10.1016/j.ijcard.2012.01.066
Comparison of left ventricular reverse remodeling induced by cardiac contractility modulation and cardiac resynchronization therapy in heart failure patients with different QRS durations
Abstract
Background: Cardiac contractility modulation (CCM) is a new device-based therapy for advanced systolic heart failure with normal QRS duration and therefore not suitable for cardiac resynchronization therapy (CRT). Left ventricular (LV) reverse remodeling was reported in patients treated with CCM or CRT, however, the extent of response was not compared.
Methods: This observational study consisted of three groups of patients with symptomatic heart failure and LV ejection fraction <35% despite optimal medical therapy. Group 1 included those received CCM with a QRS duration <120 ms (n=33), Group 2 included those received CRT with a QRS duration of 120-150 ms (n=43), and Group 3 included those received CRT with a QRS duration >150 ms (n=56). LV end-systolic volume (LVESV) was measured at baseline and 3 months later.
Results: Age, gender, etiology of heart failure and baseline ejection fraction were comparable. A significant LV reverse remodeling was observed in each group. The degree of LVESV reduction was similar between Group 1 and Group 2 (-11.3 ± 1 1.8 vs. -13.6 ± 18.3%, p=0.833), however, it was greater in Group 3 (-25.0 ± 18.0%, both p<0.01). By using the reduction ≥ 15%, the responder rate was not different between Group 1 (39%) and Group 2 (42%), but significantly higher in Group 3 (68%) (χ(2)=9.514, p=0.009).
Conclusion: CCM exhibited a similar LV reverse remodeling response to CRT for patients with a mildly prolonged QRS, though the effect was less strong when compared to CRT for patients with a very wide QRS.
Keywords: Cardiac contractility modulation; Cardiac resynchronization therapy; Reverse remodeling.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.
Similar articles
-
Cardiac contractility modulation in patients with heart failure - A review of the literature.Heart Fail Rev. 2024 May;29(3):689-705. doi: 10.1007/s10741-024-10390-1. Epub 2024 Feb 23. Heart Fail Rev. 2024. PMID: 38393423 Review.
-
Effect of QRS duration and morphology on cardiac resynchronization therapy outcomes in mild heart failure: results from the Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction (REVERSE) study.Circulation. 2012 Aug 14;126(7):822-9. doi: 10.1161/CIRCULATIONAHA.112.097709. Epub 2012 Jul 10. Circulation. 2012. PMID: 22781424 Clinical Trial.
-
Impact of ejection fraction on the clinical response to cardiac resynchronization therapy in mild heart failure.Circ Heart Fail. 2013 Nov;6(6):1180-9. doi: 10.1161/CIRCHEARTFAILURE.113.000326. Epub 2013 Sep 6. Circ Heart Fail. 2013. PMID: 24014828 Clinical Trial.
-
Cardiac resynchronization therapy in patients with systolic left ventricular dysfunction and symptoms of mild heart failure secondary to ischemic or nonischemic cardiomyopathy.Am J Cardiol. 2006 Jul 15;98(2):230-5. doi: 10.1016/j.amjcard.2006.01.080. Epub 2006 May 19. Am J Cardiol. 2006. PMID: 16828599
-
Cardiac-resynchronization therapy in patients with systolic heart failure and QRS interval ≤130 ms: insights from a meta-analysis.Europace. 2015 Feb;17(2):267-73. doi: 10.1093/europace/euu214. Epub 2014 Aug 27. Europace. 2015. PMID: 25164431 Review.
Cited by
-
Cardiac Contractility Modulation and Baroreflex Activation Therapy in Heart Failure Patients.Curr Heart Fail Rep. 2019 Feb;16(1):38-46. doi: 10.1007/s11897-019-0422-3. Curr Heart Fail Rep. 2019. PMID: 30762177 Review.
-
Recent advances in the optimization of cardiac resynchronization therapy.Curr Heart Fail Rep. 2015 Feb;12(1):48-60. doi: 10.1007/s11897-014-0234-4. Curr Heart Fail Rep. 2015. PMID: 25315038 Review.
-
Cardiac contractility modulation in patients with heart failure - A review of the literature.Heart Fail Rev. 2024 May;29(3):689-705. doi: 10.1007/s10741-024-10390-1. Epub 2024 Feb 23. Heart Fail Rev. 2024. PMID: 38393423 Review.
-
Circulating Vascular Cell Adhesion Molecule-1 (sVCAM-1) Is Associated With Left Atrial Remodeling in Long-Distance Runners.Front Cardiovasc Med. 2021 Nov 1;8:737285. doi: 10.3389/fcvm.2021.737285. eCollection 2021. Front Cardiovasc Med. 2021. PMID: 34790706 Free PMC article.
-
The safety and efficacy of cardiac contractility modulation in heart failure : A meta-analysis of clinical trials.Herz. 2017 Dec;42(8):766-775. doi: 10.1007/s00059-016-4514-5. Epub 2017 Jan 18. Herz. 2017. PMID: 28101624 English.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials